Invenra Debuted Cancer-Themed Playing Card Deck
Wisconsin-based Invenra featured patient-created artwork to inspire cancer researchers at a recent industry meeting.
Updated on Oct. 12, 2026 in Cancer
Live Poll
Do you trust pharmaceutical marketing campaigns that incorporate personal patient art to build brand awareness?
Invenra recently introduced a deck of 52 playing cards, titled 52 Views of Cancer, to encourage clinicians and scientists working on cancer cures. The company distributed the deck, which features licensed patient artwork, at the World ADC Conference.
Why it matters
By integrating the patient perspective into the clinical development space, Invenra aims to provide motivation for those developing complex antibody platforms. This initiative highlights the intersection of patient experiences and the professional search for new cancer treatments.
Invenra produced a 52-card deck featuring artwork and statements licensed from people affected by cancer. The efficacy of such outreach initiatives in shifting the landscape of scientific innovation remains a subjective and qualitative goal.
The players
Invenra
A Wisconsin-based biotechnology company that develops bispecific and trispecific antibody platforms for antibody-drug conjugate research.
The details
The deck was created to bridge the gap between bench science and the lived human experience of cancer. Invenra, which focuses on bispecific and trispecific antibody platforms for antibody-drug conjugate (ADC) development, hosts the artist statements and artwork on a dedicated website to further connect researchers with the patient community.
Timeline
October 2026: The card deck debuted at the World ADC Conference.
Health Landscape
Industry conferences like the World ADC Conference have traditionally focused on the technical rigors of drug discovery and antibody platform engineering. This development represents a shift toward incorporating the humanities and patient voices into the oncology research ecosystem.
This project highlights how those living with cancer are increasingly involved in the professional dialogue surrounding new treatments. If you are participating in a clinical trial or treatment program, discussing your patient perspective with your care team remains an important way to advocate for your own health experience.
The takeaway
Bringing the human side of oncology into the professional sphere can help sustain the long-term focus required for complex drug development. Readers interested in the patient perspective can explore how art-based advocacy is shaping community understanding of health challenges.
Further reading
For broader context on current progress in oncology research, visit Cancer.
Source note: This article includes information reported by FiercePharma.
Live Poll
Do you trust pharmaceutical marketing campaigns that incorporate personal patient art to build brand awareness?
